ARTICLE SUMMARY:
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in November 2024. Updated November 30.
A roundup of FDA’s actions in November 2024.
FDA Output, November 2024
×
